Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein
The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome that is characterized by the development of multiple vascular tumors and is caused by inactivation of the von Hippel-Lindau protein (pVHL). Here we show that pVHL, through its beta-domain, binds directly to hypoxia-inducible factor (HIF), thereby targeting HIF for ubiquitination in an alpha-domain-dependent manner. This is the first function to be ascribed to the pVHL beta-domain. Furthermore, we provide the first direct evidence that pVHL has a function analogous to that of an F-box protein, namely, to recruit substrates to a ubiquitination machine. These results strengthen the link between overaccumulation of HIF and development of VHL disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the presence of oxygen (typically > 5% O2), the HIF-α subunit is hydroxylated by PHDs in an iron and oxygen dependent manner, which leads to HIF-α polyubiquitination by pVHL, targeting HIF-α for proteasomal degradation (Figure 2) [8].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [8]
In the citing paper
“As described in the AdPROM section, VHL acts as the substrate receptor for the Cul2-Rbx1 E3 ligase complex, recruiting HIF1α for its ubiquitination and degradation [88].”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [88]
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 1×
“Whether hypoxia and desferroxamine utilize the same molecular mechanism(s) to stabilize HIF in vivo remains to be determine”
BackgroundSalceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Self-citationStabilization of wild-type p53 by hypoxia-inducible factor 1α
An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. M. (1998) · Nature · doi:10.1038/32925 · Cited by 827
Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway
Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y., & Poellinger, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6519 · Cited by 754
Tumour suppression by the human von Hippel-Lindau gene product
Iliopoulos, O., Kibel, A., Gray, S., & Kaelin, W. G. (1995) · Nature Medicine · doi:10.1038/nm0895-822 · Cited by 703
Self-citationBinding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
Kibel, A., Iliopoulos, O., DeCaprio, J. A., & Kaelin, W. G. (1995) · Science · doi:10.1126/science.7660130 · Cited by 671 · cited 1×
“pVHL normally exists in cells as a complex with elongin B and elongin C rather than as a monome”
BackgroundSelf-citationKamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W. G., Conaway, R. C., & Conaway, J. W. (1998) · Genes & Development · doi:10.1101/gad.12.24.3872 · Cited by 595 · cited 1×
“pVHL normally exists in cells as a complex with elongin B and elongin C rather than as a monome”
BackgroundSelf-citation
Cited by
Items 801–900 of 1,005
Editorial: Molecular Targeting of VHL Gene Pathway in Clear Cell Kidney Cancer
Linehan, W. M. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000077210.05543.ae · Cited by 36
Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance
Kubaichuk, K. I., & Kietzmann, T. (2019) · Cells · doi:10.3390/cells8060598 · Cited by 41
Nishimura, R., & Okuda, K. (2015) · Reproduction Fertility and Development · doi:10.1071/rd15010 · Cited by 37
“1998) that interacts with the vonHippel-Lindau E3 ubiquitin ligase complex (Maxwell et al. 1999; Cockman et al. 2000; Kamura et al. 2000; Ohh et al. 2000; Tanimoto et al. 2000) that targets HIFa for proteasomal destruction under normoxia (Salceda and Caro 1997; Huang et al.”
BackgroundViola, R. J., Provenzale, J. M., Li, F., Li, C., Yuan, H., Tashjian, J. A., & Dewhirst, M. W. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.4060 · Cited by 40
“The oxygendependent degradation domain of HIF-1α is modified by a family of hydroxylases, which use oxygen as a cofactor, allowing recognition by the ubiquitin ligase von Hippel-Lindau complex [6].”
BackgroundDrosophila von Hippel-Lindau Tumor Suppressor Complex Possesses E3 Ubiquitin Ligase Activity
Aso, T., Yamazaki, K., Aigaki, T., & Kitajima, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3451 · Cited by 35
Feeding the machine: mechanisms of proteasome-catalyzed degradation of ubiquitinated proteins
Crews, C. M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.08.002 · Cited by 39
Phillips, J. L., Pavlovich, C. P., Walther, M. M., Ried, T., & Linehan, W. M. (2001) · Current Opinion in Urology · doi:10.1097/00042307-200109000-00003 · Cited by 35
Intestinal oxygen utilisation and cellular adaptation during intestinal ischaemia–reperfusion injury
Barakakis, P. A., Mavridis, T., Chlorogiannis, D., Barakakis, G., Laou, E., Sessler, D. I., Gkiokas, G., & Chalkias, A. F. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70136 · Cited by 34
Ban, H. S., Uno, M., & Nakamura, H. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.03.010 · Cited by 37
“Under the aerobic condition, proline residues in HIF-1a undergo hydroxylation by prolyl hydroxylase (PHD) and the hydroxylated HIF-1a binds to the von Hippel-Lindau (VHL) tumor suppressor protein, a component of the E3 ubiquitin ligase complex [3,4].”
BackgroundGarje, R., An, J., Sanchez, K. G., Greco, A., Stolwijk, J. M., Devor, E. J., Rustum, Y. M., & Zakharia, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123834 · Cited by 41
“Hence, this leads to HIFα accumulation and formation of heterodimer complex with HIF1β and subsequent induction of several target genes in the nucleus [15,16].”
BackgroundGanesh, S., Horvat, F., Drutovič, D., Blažíková, M., Pinkas, D., Jindrova, A., Pasulka, J., Iyyappan, R., Malík, R., Šušor, A., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1239 · Cited by 36
Chemical Approaches to Controlling Intracellular Protein Degradation
Schneekloth, J. S., & Crews, C. M. (2004) · ChemBioChem · doi:10.1002/cbic.200400274 · Cited by 34
Schraml, P., Hergovitz, A., Hatz, F., Amin, M. B., Lim, S. D., Krek, W., Mihatsch, M. J., & Moch, H. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63461-x · Cited by 38
“pVHL is a component of an E3 ubiquitin-protein ligase(10) that regulates the stability of HIF transcription factor.(11,12) pVHL targets proteins for ubiquitin-mediated degradation.”
BackgroundBC-box protein domain-related mechanism for VHL protein degradation
Pozzebon, M. E., Varadaraj, A., Mattoscio, D., Jaffray, E., Miccolo, C., Galimberti, V. E., Tommasino, M., Hay, R. T., & Chiocca, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311382110 · Cited by 34
Miyake, M., Goodison, S., Lawton, A., Zhang, G., Gomes-Giacoia, E., & Rosser, C. J. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-65 · Cited by 35
“When the HIF complex translocates to the nucleus it binds to hypoxia-response elements of DNA leading to the regulation of multiple hypoxia-inducible genes [6,7].”
BackgroundDevelopmentally arrested structures preceding cerebellar tumors in von Hippel–Lindau disease
Shively, S. B., Falke, E., Li, J., Tran, M. G. B., Thompson, E. R., Maxwell, P. H., Roessler, E., Oldfield, E. H., Lonser, R. R., & Vortmeyer, A. O. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.61 · Cited by 35
Daam2 driven degradation of VHL promotes gliomagenesis
Zhu, W., Krishna, S., Garcia, C., Lin, C.-C. J., Mitchell, B. D., Scott, K. L., Mohila, C., Creighton, C. J., Yoo, S. H., Lee, H. K., et al. (2017) · eLife · doi:10.7554/elife.31926 · Cited by 36
Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1
Chu, S., Feng, D., Ma, Y., Zhu, Z.-A., Zhang, H., & Qiu, J. (2008) · Molecular Biology Reports · doi:10.1007/s11033-008-9406-1 · Cited by 35
Role of the ubiquitin proteasome system in renal cell carcinoma
Corn, P. G. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s4 · Cited by 40
“htm) are missense mutations and many lead to aberrant upregulation of HIF-1, either by abolishing binding of pVHL to Elongin C and/or to HIFα proteins (reviewed in 3) [3,62,63].”
BackgroundHIF1α-dependent uncoupling of glycolysis suppresses tumor cell proliferation
Urrutia, A. A., Mesa‐Ciller, C., Guajardo-Grence, A., Alkan, H. F., Soro-Arnáiz, I., Vandekeere, A., Campos, A. M. F., Igelmann, S., Fernández-Arroyo, L., Rinaldi, G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114103 · Cited by 34
Metabolic Signaling in the Tumor Microenvironment
Clay, R., Li, K., & Jin, L. (2025) · Cancers · doi:10.3390/cancers17010155 · Cited by 36
Regulation of hypoxia-inducible factor 1 by glucose availability under hypoxic conditions.
Zhou, J., Hara, K., Inoue, M., Hamada, S., Yasuda, H., Moriyama, H., Endo, H., Hirota, K., Yonezawa, K., Nagata, M., et al. (2008) · Institutional Repositories DataBase (IRDB) · doi:10.24546/81000128 · Cited by 35
Fuse, S., Ohuchi, T., Asawa, Y., Sato, S., & Nakamura, H. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.11.009 · Cited by 33
Robinson, C. M., Poon, B., Kano, Y., Pluthero, F. G., Kahr, W. H. A., & Ohh, M. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0461 · Cited by 33
“Multiple targets of VHL have been proposed but its involvement in the degradation of the alpha subunit of transcription factors called hypoxia-inducible factors (HIF), of which there are three (HIF1a, -2a, and -3a) inmammals, is the best described VHL target (5, 6).”
BackgroundSelf-citationOxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship
Pandkar, M. R., Dhamdhere, S. G., & Shukla, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188553 · Cited by 36
Biochemistry of the hypoxia-inducible factor hydroxylases
Fiorini, G., & Schofield, C. J. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102428 · Cited by 35
Schlisio, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00881.x · Cited by 38
“Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd Lindau (VHL) acts as an ubiquitin ligase by targeting hydroxylated HIF- for degradation when oxygen is available, as where under low oxygen environments, HIF- escapes hydroxylation and subsequently escapes VHL recognitio…”
BackgroundN-myc downstream regulated 1 gene and its place in the cellular machinery.
Kitowska, A., & Pawełczyk, T. (2010) · Acta Biochimica Polonica · doi:10.18388/abp.2010_2367 · Cited by 38
Hypoxia-inducible factors: Crosstalk between their protein stability and protein degradation
Wei, W., & Yu, X. D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.009 · Cited by 34
Kim, B., & Forbes, N. S. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21205 · Cited by 36
“The concentration of HIF-1a, which is constitutively expressed, is regulated by oxygen through ubiquitin-mediated degradation (Huang et al., 1998; Salceda and Caro, 1997) mediated by the Von Hippel-Lindau Factor (Cockman et al., 2000; Kamura et al., 2000; Ohh et al., 2000).”
BackgroundHow many pathways to pheochromocytoma?
Neumann, H. P. H., Hoegerle, S., Manz, T., BRENNER, K. R., & Iliopoulos, O. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.30207 · Cited by 37
Drug Insight: advances in renal cell carcinoma and the role of targeted therapies
Larkin, J., Chowdhury, S., & Gore, M. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0901 · Cited by 36
VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation
Wang, Z., Yan, M., Ye, L., Zhou, Q., Duan, Y., Jiang, H., Wang, L., Ouyang, Y., Zhang, H., Shen, Y., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00051-2 · Cited by 37
“…HIF1/2 α ubiquitylation and degradation under normoxic conditions, but not hypoxic conditions, in which the activity of PHDs is inhibited by low O 2 levels, resulting in enhanced HIF1/2 α expression to induce downstream gene expression (Lisztwan et al, 1999; Ohh et al, 2000; Tanimoto et al, 2000).”
Zhang, W., Li, L., Cai, L., Liang, Y., Xu, J., Liu, Y., Zhou, L., Ding, C., Zhang, Y., Zhao, H., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00724-5 · Cited by 32
“HIF1α is the best known CRL2 substrate that binds to the substrate receptor protein VHL for ubiquitination and degradation [52, 53].”
BackgroundKnauth, K., Cartwright, E. J. P., Freund, S. M. V., Bycroft, M., & Buchberger, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809056200 · Cited by 35
Chakraborty, C., George, C., Chen, L., & Zhu, H. (2014) · Current Protein and Peptide Science · doi:10.2174/1389203715666140724090153 · Cited by 34
Sakamoto, J., Origuchi, T., Okita, M., Nakano, J., Kato, K., Yoshimura, T., Izumi, S., Komori, T., Nakamura, H., Ida, H., et al. (2009) · Connective Tissue Research · doi:10.1080/03008200802412454 · Cited by 33
CUL2 Is Required for the Activity of Hypoxia-inducible Factor and Vasculogenesis
Maeda, Y., Suzuki, T., Pan, X., Chen, G., Pan, S., Bartman, T., & Whitsett, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710223200 · Cited by 32
Qian, F., He, M., Duan, W., Mao, L., Li, Q., Yu, Z., Zhou, Z., & Zhang, Y. (2015) · PubMed · Cited by 32
Ban, H. S., Naik, R., Kim, H. M., Kim, B., Lee, H., Kim, I., Ahn, H., Jang, Y., Jang, K., Eo, Y., et al. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00305 · Cited by 33
Spicer, Z., & Millhorn, D. E. (2003) · Endocrine Pathology · doi:10.1385/ep:14:4:277 · Cited by 34
“VHL binds to the ODD through its β domain and targets the HIF complex for ubiquitination [74].”
BackgroundShao, G., Gao, C.-Y., & Lu, G. (2005) · Neurosignals · doi:10.1159/000088641 · Cited by 32
“The von Hippel-Lindau tumor suppressor protein, a ubiquitin protein ligase, recognizes HIF-1α that has been modified at the two proline residues and binds to a region of HIF-1α named oxygen-dependent degradation domain [”
BackgroundSignal transduction targets in Kaposi's sarcoma
Sullivan, R. J., Dezube, B. J., & Koon, H. B. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000239884.05914.13 · Cited by 33
Protein kinase C‐δ regulates the stability of hypoxia‐inducible factor‐1α under hypoxia
Lee, J., Park, J. A., Kim, S., Seo, J. H., Lim, K., Jeong, J., Jeong, C., Chun, K., Lee, S., Kwon, Y., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00535.x · Cited by 35
Jensen, R. L., Gillespie, D. L., House, P. A., Layfield, L. J., & Shelton, C. (2004) · Journal of neurosurgery · doi:10.3171/jns.2004.100.3.0488 · Cited by 32
HIF-independent oxygen sensing via KDM6A regulates ferroptosis
Minikes, A. M., Liu, P., Wang, H., Hu, J., Alwaseem, H., Li, Y., & Jiang, X. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.07.001 · Cited by 32
Molecular Biology of Renal Cortical Tumors
Klatte, T., & Pantuck, A. J. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.006 · Cited by 31
Angiogenesis as a new target for cancer control
Harris, A. L. (2003) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(03)00007-7 · Cited by 36
Genetic and Pharmacological Strategies to Refunctionalize the von Hippel Lindau R167Q Mutant Protein
Ding, Z., Germán, P., Bai, S., Reddy, A. S., Liu, X.-D., Sun, M., Zhou, L., Chen, X., Zhao, X., Wu, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3213 · Cited by 31
“The establishment of VHL as the substrate recognizing component of an E3 ligase for hypoxia inducible factor (HIF) has led to an understanding that loss of VHL function and stabilization of HIF play a central role in tumor angiogenesis in ccRCC (2-4).”
InfluentialThe role of ubiquitination in the regulation of primary cilia assembly and disassembly
Hossain, D., & Tsang, W. Y. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.09.005 · Cited by 32
Erber, L. N., Luo, A., & Chen, Y. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001535 · Cited by 31
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes
Büscheck, F., Fraune, C., Simon, R., Kluth, M., Hube‐Magg, C., Möller‐Koop, C., Sarper, I., Ketterer, K., Henke, T. L. C., Eichelberg, C., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27428 · Cited by 31
Mdm2-mediated neddylation of pVHL blocks the induction of antiangiogenic factors
Wolf, E. R., Mabry, A., Damania, B., & Mayo, L. D. (2020) · Oncogene · doi:10.1038/s41388-020-1359-4 · Cited by 31
Molecular and physiological roles of Pellino E3 ubiquitin ligases in immunity
Humphries, F., & Moynagh, P. N. (2015) · Immunological Reviews · doi:10.1111/imr.12306 · Cited by 34
“Under normoxic conditions HIF1a is modified by proline hydroxylation resulting in its K48-linked polyubiquitination and proteasomal degradation (123, 124) whereas in hypoxia, the low levels of oxygen precludes hydroxylation of HIF-1a resulting in its stabilization.”
BackgroundHe, X., Wang, J., Messing, E. M., & Wu, G. (2010) · Oncogene · doi:10.1038/onc.2010.427 · Cited by 31
“E-mail: guan_wu@urmc.rochester.edu Oncogene (2011) 30, 535–547 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc -2a for oxygen-dependent degradation and regulates cellular response to hypoxia (Maxwell et al., 1999; Ohh et al., 2000).”
BackgroundHarada, H., Kizaka‐Kondoh, S., & Hiraoka, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.025 · Cited by 31
Gérard, A.-C., Poncin, S., Audinot, J., Denef, J., & Colin, I. M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90876.2008 · Cited by 33
“By contrast, this ongoing protein degradation is suppressed under hypoxic conditions (9, 18, 19, 24, 25, 28).”
BackgroundAngiogenesis regulation by nanocarriers bearing RNA interference
Ofek, P., Tiram, G., & Satchi‐Fainaro, R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.01.008 · Cited by 31
“In the presence of oxygen, HIF-1α is bound to the tumor suppressor Von Hippel–Lindau (VHL) that causes HIF-1α to become ubiquitylated and degraded by the proteasome [137,138].”
BackgroundKuwai, T., Kitadai, Y., Tanaka, S., Hiyama, T., Tanimoto, K., & Chayama, K. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03196.x · Cited by 34
The BTB Protein MEL-26 Promotes Cytokinesis in C. elegans by a CUL-3-Independent Mechanism
Luke-Glaser, S., Pintard, L., Lu, C., Mains, P. E., & Peter, M. (2005) · Current Biology · doi:10.1016/j.cub.2005.07.068 · Cited by 32
Ruiz‐Llorente, S., Bravo, J., Cebrián, A., Cascón, A., Pollán, M., Tellería, D., Letón, R., Urioste, M., Rodríguez‐López, R., de Campos, J. M., et al. (2004) · Human Mutation · doi:10.1002/humu.10309 · Cited by 34
“They are also associated with the ubiquitin-dependent proteolysis [Ohh et al., 2000], inhibition of apoptosis [Devarajan et al., 2001], cell cycle exit [Pause et al., 1998], and fibronectin matrix assembly [Ohh et al., 1998].”
Inhibition of SRC Corrects GM-CSF Hypersensitivity That Underlies Juvenile Myelomonocytic Leukemia
Bunda, S., Kang, M. W., Sybingco, S. S., Weng, J., Favre, H., Shin, D. H., Irwin, M. S., Loh, M. L., & Ohh, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3425 · Cited by 32
“Immunoprecipitation and immunoblotting Immunoprecipitation and Western blotting were done as described previously (16).”
MethodSelf-citationChen, K., Gan, Y., Gumireddy, K., Li, A., Yao, W., Gao, L., Chen, S., Hao, J., Wang, J., Huang, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3134 · Cited by 30
“C/elongin B/Cul2/Rbx1 complex binding site and the β-domain plays a role in the substrate recognition [8].”
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
Mahalingam, D., Espitia, C. M., Medina, E. C., Esquivel, J., Kelly, K. R., Bearss, D. J., Choy, G. S., Taverna, P., Carew, J. S., Giles, F. J., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.426 · Cited by 35
“…being transcribed, but are targeted for proteasomal degradation under normoxic conditions by the VHL E3 ubiquitin ligase (Iliopoulos et al, 1996; Ohh et al, 2000). von Hippel-Lindau-defective tumours have high levels of HIFa and can be subdivided into two groups, tumours with both HIF-1a and…”
BackgroundPlafker, K. S., & Plafker, S. M. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-06-1057 · Cited by 34
“It does so by degrading oxidatively damaged proteins (e.g., Dudek et al., 2005) by regulating the stability of cytoprotective proteins (e.g., HIF1α; Salceda and Caro, 1997; Huang et al., 1998; Ohh et al., 2000).”
BackgroundGenotype-phenotype correlations in Chinese von Hippel-Lindau disease patients
Peng, S., Shepard, M. J., Wang, J., Li, T., Ning, X., Cai, L., Zhuang, Z., & Gong, K. (2017) · Oncotarget · doi:10.18632/oncotarget.16594 · Cited by 30
“Oncotarget38461www.impactjournals.com/oncotarget with the finding that in patients with Type 2C VHL, pVHL remains able to downregulate HIF, thereby explaining the absence of RCC and CHB [12, 32, 33].”
King, M. J., Bukantz, S. C., Phillips, S. E., Mohapatra, S. S., Tamulis, T., & Lockey, R. F. (2004) · PubMed · Cited by 34
Blagosklonny, M. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204055 · Cited by 32
“…this link, it has been demonstrated that VHL binds to HIF-1a and targets it for degradation under normal oxygen conditions (Maxwell et al., 1999). pVHL, through its b-domain, binds directly to HIF, thereby targeting HIF for ubiquitination in an a-domain-dependent manner (Ohh et al., 2000).”
BackgroundFisher, R. A., Larkin, J., & Swanton, C. (2011) · The EPMA Journal · doi:10.1007/s13167-011-0137-3 · Cited by 29
“The VHL protein (pVHL) regulates hypoxia-inducible factor (HIF) by ubiquitin-mediated destruction [26,27] and in the absence of functional pVHL, HIF activates a number of hypoxiaresponse genes such as vascular endothelial growth factor (VEGF), erythropoietin (Epo), platelet derived growth factor (PDGF), TFG-a and -b,…”
BackgroundTumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
DiGiacomo, J. W., & Gilkes, D. M. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0555-4 · Cited by 31
“lows for ubiquitination by the von Hippel-Lindau (VHL) tumor suppressor protein which targets the subunits for degradation by the proteasome [35, 36].”
BackgroundBRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
Li, A. G., Murphy, E. C., Culhane, A. C., Powell, E., Wang, H., Bronson, R. T., Von, T., Giobbie‐Hurder, A., Gelman, R. S., Briggs, K. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807112115 · Cited by 29
Self-citationProgression of Epididymal Maldevelopment Into Hamartoma-like Neoplasia in VHL Disease
Mehta, G. U., Shively, S. B., Duong, H. T., Tran, M. G. B., Moncrief, T. J., Smith, J. H., Li, J., Edwards, N. A., Lonser, R. R., Zhuang, Z., et al. (2008) · Neoplasia · doi:10.1593/neo.08476 · Cited by 29
Baby, S. M., Roy, A., Mokashi, A., & Lahiri, S. (2003) · Histochemistry and Cell Biology · doi:10.1007/s00418-003-0588-2 · Cited by 30
“The ubiquitylation modification targets HIF-1a for proteasomal degradation (Salceda and Caro 1997; Kamura et al. 2000; Ohh et al. 2000).”
BackgroundRecent advances in the systemic treatment of metastatic papillary renal cancer
Chowdhury, S., & Choueiri, T. K. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.9.3.373 · Cited by 32
Xu, Y., Li, Y., Li, H., Pang, Y., Zhao, Y., Jiang, R., Shen, L., Zhou, J., Wang, X., & Liu, Q. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.11.014 · Cited by 31
The Role of Ubiquitination in Regulating Embryonic Stem Cell Maintenance and Cancer Development
Wang, D., Bu, F., & Zhang, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112667 · Cited by 35
Dodge‐Kafka, K. L., Turcotte, M. G., Tokarski, K., & Kapiloff, M. S. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109357 · Cited by 29
Insights into the Role of the von Hippel-Lindau Gene Product
Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · Nephron Experimental Nephrology · doi:10.1159/000052617 · Cited by 31
“This leads to a constitutive HIF response, with activation of hypoxia response elements and increased transcription of a wide range of HIF target genes, which include VEGF. In cells containing pVHL and HIFa subunits the proteins co-immunoprecipitated, strongly suggesting that pVHL functioned as the specific recognitio…”
MethodBeyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau
Roberts, A. M., & Ohh, M. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f310de · Cited by 30
Self-citationBangiyeva, V., Rosenbloom, A., Alexander, A. E., Isanova, B., Popko, T., & Schoenfeld, A. R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-229 · Cited by 30
“One target substrate that has been overwhelmingly confirmed for the pVHL E3 ubiquitin ligase complex is hypoxia-inducible factor alpha (HIF-α) [20-23].”
BackgroundWu, K. L., Miao, H., & Khan, S. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00096.2007 · Cited by 30
“Invasion through Matrigel was also assessed in RCC expressing dominant-negative JAK constructs: TYK2 (1-895), also referred to as TYK2 ( TK), which has a tyrosine kinase domain deletion, as well as two JAK2-inactivating point mutants (K882E and Y1007F).”
BackgroundSun, X., Kanwar, J. R., Leung, E. Y., Vale, M., & Krissansen, G. W. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302118 · Cited by 35
Paulding, W. R., Schnell, P. O., Bauer, A. L., Striet, J. B., Nash, J. A., Kuznetsova, A. V., & Czyzyk-Krzeska, M. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10192 · Cited by 35
“…(pVHL) tumor suppressor protein regulates degradation of HIF- subunits (Maxwell et al., 1999; Cockman et al., 2000; Kamura et al., 2000; Ohh et al., 2000; Ivan et al., 2001; Jaakkola et al., 2001). pVHL functions as part of a multiprotein complex containing elongins BC, RING finger…”
Fu, C., Tyagi, R., Chin, A. C., Rojas, T., Li, R.-J., Guha, P., Bernstein, I. A., Rao, F., Xu, R., Cha, J. Y., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311983 · Cited by 28
Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
Taneja, S., Vetter, S. W., & Leclerc, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158153 · Cited by 28
Todd, V. M., Vecchi, L. A., Clements, M. E., Snow, K. P., Ontko, C. D., Himmel, L. E., Pinelli, C. J., Rafat, M., & Johnson, R. W. (2021) · Communications Biology · doi:10.1038/s42003-021-02648-3 · Cited by 29
Role of Hypoxia in the Interferon Response
Arnaiz, E., & Harris, A. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821816 · Cited by 30
Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype
Lee, S. C.-E. S., Pyo, A. H. A., & Koritzinsky, M. (2023) · Science Advances · doi:10.1126/sciadv.adj6409 · Cited by 31
“Under hypoxia, the HIFα sub-units are thus stabilized due to the inability of PHDs to hydroxylate them ( 52 ).”
BackgroundAdrenomedullin promotes human endothelial cell proliferation via HIF-1α
Chen, L., Qiu, J., Zhang, L., & Luo, X.-D. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1267-1 · Cited by 33
Chen, K., Chen, S., Huang, C., Cheng, H., & Zhou, R. (2013) · Biology of the Cell · doi:10.1111/boc.201200080 · Cited by 29
“It has been shown that the β domain of VHL is associated with HIF1α (Maxwell et al., 1999; Ohh et al., 2000).”
BackgroundTonissen, K. F., & Poulsen, S. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2020.110 · Cited by 28
“The VHL-encoded protein binds to HIF-1 resulting in its ubiquitin dependent degradation([28]).”
BackgroundExpression of p53 in renal carcinoma cells is independent of pVHL
Stickle, N. H., Cheng, L. S., Watson, I. R., Alon, N., Malkin, D. M., Irwin, M. S., & Ohh, M. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.02.016 · Cited by 28
Self-citationHypoxia in Skin Cancer: Molecular Basis and Clinical Implications
Jeon, S., Jeon, M., Choi, S., Yoo, S., Park, S.-H., Lee, M., & Kim, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054430 · Cited by 28
Shin, J. M., Kim, J., Kim, H. E., Lee, M., Lee, K. I., Yoo, E. G., Jeon, Y. J., Kim, J. C., & Chung, H. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.06.002 · Cited by 27
Kaluz, Š., Kaluzová, M., & Stanbridge, E. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21644 · Cited by 31
“Subdomain a binds directly to elongin C and subdomain b binds directly to HIF-a [Ohh et al., 2000].”
BackgroundInteractions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif
Wang, X., Wang, X., Zhang, H., Lv, M., Zuo, T., Wu, H., Wang, J., Liu, D., Wang, C., Zhang, J., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-94 · Cited by 27
“All results [53], as EloB is known to stabilize EloC and form an obligate heterodimer with EloC [13,38-42].”
BackgroundYang, Y., Fu, Q., Wang, X., Liu, Y., Zeng, Q., Li, Y., Gao, S., Bao, L., Liu, S., Gao, D., et al. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00125.2017 · Cited by 30
“4 through HIF1-α protein, which is degraded under normal oxygen conditions (13, 45, 52, 70).”
BackgroundDiscoveries of how cells sense oxygen win the 2019 Nobel Prize in Physiology or medicine
Lee, C., Wu, C., & Yang, H. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.05.019 · Cited by 32
The roles of E3 ligases in Hepatocellular carcinoma.
Yu, Z., Li, H., Zhu, J., Wang, H., & Jin, X. (2022) · PubMed · Cited by 31
PKM2 dictates the poised chromatin state of PFKFB3 promoter to enhance breast cancer progression
Pandkar, M. R., Raveendran, A., Biswas, K., Mutnuru, S. A., Mishra, J., Samaiya, A., Malys, T., Mitrophanov, A. Y., Sharan, S. K., & Shukla, S. (2023) · NAR Cancer · doi:10.1093/narcan/zcad032 · Cited by 28
Metadata
- Authors
- Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Memorial Sloan Kettering Cancer Center (US)
- Pennsylvania State University (US)
- Corresponding author
- Kaelin, William G.
- Venue
- Nature Cell Biology
- Published
- 2000-06-09
- Volume
- 2
- Issue
- 7
- Pages
- 423-427
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2147718842
- Cited by
- 1,577
- References
- 21
- Citations by year
- 2026: 23 · 2025: 36 · 2024: 46 · 2023: 36 · 2022: 49 · 2021: 56 · 2020: 59 · 2019: 45 · 2018: 40 · 2017: 50 · 2016: 52 · 2015: 45 · 2014: 62 · 2013: 66 · 2012: 70
- FWCI
- 33.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- von Hippel-Lindau protein, hypoxia-inducible factor, ubiquitination, F-box protein, protein-protein interaction, alpha-domain, von Hippel-Lindau disease, tumor suppressor, vascular tumors, E3 ubiquitin ligase
- MeSH terms
- Elongin, Cell Extracts, Deferoxamine, DNA-Binding Proteins, HeLa Cells, Humans, Ligases, Mutation, Nuclear Proteins, Oxygen, Protein Binding, Protein Processing, Post-Translational, Proteins, Transcription Factors, Transfection, Tumor Cells, Cultured, Ubiquitins, Protein Structure, Tertiary, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.